Cargando…
Autoantibodies to Oxidatively Modified Peptide: Potential Clinical Application in Coronary Artery Disease
Coronary artery disease (CAD) is a global health issue. Lipid peroxidation produces various by-products that associate with CAD, such as 4-hydroxynonenal (HNE) and malondialdehyde (MDA). The autoantibodies against HNE and MDA-modified peptides may be useful in the diagnosis of CAD. This study includ...
Autores principales: | Tsai, I-Jung, Shen, Wen-Chi, Wu, Jia-Zhen, Chang, Yu-Sheng, Lin, Ching-Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600024/ https://www.ncbi.nlm.nih.gov/pubmed/36291959 http://dx.doi.org/10.3390/diagnostics12102269 |
Ejemplares similares
-
Using Anti-Malondialdehyde Modified Peptide Autoantibodies to Import Machine Learning for Predicting Coronary Artery Stenosis in Taiwanese Patients with Coronary Artery Disease
por: Hsu, Yu-Cheng, et al.
Publicado: (2021) -
Isotypes of autoantibodies against novel differential 4-hydroxy-2-nonenal-modified peptide adducts in serum is associated with rheumatoid arthritis in Taiwanese women
por: Tsai, Kai-Leun, et al.
Publicado: (2021) -
A Coronary Artery Disease Monitoring Model Built from Clinical Data and Alpha-1-Antichymotrypsin
por: Chang, Chen-Chi, et al.
Publicado: (2022) -
Autoantibody and T cell responses to oxidative post-translationally modified insulin neoantigenic peptides in type 1 diabetes
por: Strollo, Rocky, et al.
Publicado: (2022) -
Autoantibodies Against Methylglyoxal-Modified Apolipoprotein B100 and ApoB100 Peptide Are Associated With Less Coronary Artery Atherosclerosis and Retinopathy in Long-Term Type 1 Diabetes
por: Sveen, Kari Anne, et al.
Publicado: (2021)